TSTL Stock Overview
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 3/6 |
Tristel plc Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | UK£4.65 |
| 52 Week High | UK£5.04 |
| 52 Week Low | UK£3.15 |
| Beta | 0.28 |
| 1 Month Change | -2.52% |
| 3 Month Change | 10.71% |
| 1 Year Change | 37.78% |
| 3 Year Change | -30.60% |
| 5 Year Change | 51.22% |
| Change since IPO | 830.00% |
Recent News & Updates
Recent updates
Tristel (LON:TSTL) Will Be Hoping To Turn Its Returns On Capital Around
Jan 27
Tristel plc Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next
Oct 19Some Investors May Be Worried About Tristel's (LON:TSTL) Returns On Capital
Oct 10An Intrinsic Calculation For Tristel plc (LON:TSTL) Suggests It's 26% Undervalued
Sep 13Tristel (LON:TSTL) Is Reinvesting At Lower Rates Of Return
Jun 23A Look At The Fair Value Of Tristel plc (LON:TSTL)
Dec 01Tristel (LON:TSTL) Could Be Struggling To Allocate Capital
Aug 03Tristel plc (LON:TSTL) Shares Could Be 22% Below Their Intrinsic Value Estimate
May 28Bearish: Analysts Just Cut Their Tristel plc (LON:TSTL) Revenue and EPS estimates
Feb 24Tristel plc (LON:TSTL) Shares Could Be 34% Below Their Intrinsic Value Estimate
Nov 17Tristel's (LON:TSTL) Soft Earnings Are Actually Better Than They Appear
Oct 26We Like Tristel's (LON:TSTL) Returns And Here's How They're Trending
Oct 13Tristel plc's (LON:TSTL) Intrinsic Value Is Potentially 44% Above Its Share Price
May 26Here's Why I Think Tristel (LON:TSTL) Is An Interesting Stock
Apr 16Read This Before Buying Tristel plc (LON:TSTL) For Its Dividend
Mar 30Did Tristel plc (LON:TSTL) Insiders Sell Shares?
Mar 15Is Tristel (LON:TSTL) The Next Multi-Bagger?
Mar 02Tristel plc's (LON:TSTL) Stock On An Uptrend: Could Fundamentals Be Driving The Momentum?
Feb 15Tristel (LON:TSTL) Has Rewarded Shareholders With An Exceptional 381% Total Return On Their Investment
Feb 03
What Type Of Shareholders Own The Most Number of Tristel plc (LON:TSTL) Shares?
Jan 20Is Now The Time To Put Tristel (LON:TSTL) On Your Watchlist?
Jan 05A Look At The Fair Value Of Tristel plc (LON:TSTL)
Dec 21Three Things You Should Check Before Buying Tristel plc (LON:TSTL) For Its Dividend
Dec 08Are Insiders Selling Tristel plc (LON:TSTL) Stock?
Nov 26Shareholder Returns
| TSTL | GB Medical Equipment | GB Market | |
|---|---|---|---|
| 7D | -3.1% | -1.0% | -0.7% |
| 1Y | 37.8% | -8.5% | -1.8% |
Return vs Industry: TSTL exceeded the UK Medical Equipment industry which returned -7.8% over the past year.
Return vs Market: TSTL exceeded the UK Market which returned -2.4% over the past year.
Price Volatility
| TSTL volatility | |
|---|---|
| TSTL Average Weekly Movement | 3.8% |
| Medical Equipment Industry Average Movement | 7.9% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in GB Market | 11.5% |
| 10% least volatile stocks in GB Market | 2.6% |
Stable Share Price: TSTL has not had significant price volatility in the past 3 months.
Volatility Over Time: TSTL's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1993 | 208 | Paul Swinney | tristel.com |
Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers medical instrument disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand.
Tristel plc Fundamentals Summary
| TSTL fundamental statistics | |
|---|---|
| Market cap | UK£220.99m |
| Earnings (TTM) | UK£6.04m |
| Revenue (TTM) | UK£39.49m |
36.6x
P/E Ratio5.6x
P/S RatioIs TSTL overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| TSTL income statement (TTM) | |
|---|---|
| Revenue | UK£39.49m |
| Cost of Revenue | UK£6.91m |
| Gross Profit | UK£32.58m |
| Other Expenses | UK£26.54m |
| Earnings | UK£6.04m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.13 |
| Gross Margin | 82.49% |
| Net Profit Margin | 15.29% |
| Debt/Equity Ratio | 0% |
How did TSTL perform over the long term?
See historical performance and comparison